Rooney S A, Gobran L I
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06510.
Biochim Biophys Acta. 1988 May 2;960(1):98-106. doi: 10.1016/0005-2760(88)90014-8.
Previous studies have shown that secretion of phosphatidylcholine in cultured adult rat type II pneumocytes is stimulated by purinoceptor agonists and leukotrienes. The objective of the present study was to determine if such agents have a physiological role in the regulation of surfactant secretion. We chose the newborn rabbit as the experimental model, since in this system there is a marked increase in surfactant secretion immediately after birth. We examined the effects of an inhibitor of leukotriene biosynthesis, nordihydroguaiaretic acid, two leukotriene antagonists, FPL-55712 and FPL-57231, and a P1 purinoceptor antagonist, 8-phenyltheophylline, on this increase. Newborn rabbits were delivered by Cesarean section at 30 days gestation. Some animals in each litter were killed immediately, while others were injected with test agents or solvent vehicle while still in the amniotic sacs. After breathing for 3 h in an incubator, these animals were also killed. The lungs were lavaged with saline and the phospholipid content and composition of the lung lavage liquid was measured. In control animals, there was a greater than 2-fold increase in the amounts of total phospholipid and phosphatidylcholine and in the phosphatidylcholine/sphingomyelin ratio during the 3 h period of breathing. The increases in total phospholipid and phosphatidylcholine were decreased 38-62% by the antagonists, while the increase in the phosphatidylcholine/sphingomyelin ratio was decreased 61-77%. These data show that the ventilation-induced increase in secretion of lung surfactant in the newborn rabbit is inhibited by leukotriene and P1 receptor antagonists and by an inhibitor of leukotriene biosynthesis and, when taken together with the data from the tissue culture system, support a role for leukotrienes and adenosine in the physiological regulation of surfactant secretion.
以往的研究表明,嘌呤受体激动剂和白三烯可刺激成年大鼠II型肺细胞培养物中磷脂酰胆碱的分泌。本研究的目的是确定这些物质在表面活性剂分泌调节中是否具有生理作用。我们选择新生兔作为实验模型,因为在这个系统中出生后表面活性剂分泌会立即显著增加。我们研究了白三烯生物合成抑制剂去甲二氢愈创木酸、两种白三烯拮抗剂FPL - 55712和FPL - 57231以及一种P1嘌呤受体拮抗剂8 - 苯基茶碱对这种增加的影响。新生兔在妊娠30天时通过剖宫产分娩。每窝中的一些动物立即处死,而其他动物在仍处于羊膜囊时注射受试药物或溶剂载体。在培养箱中呼吸3小时后,这些动物也被处死。用盐水冲洗肺部并测量肺灌洗液的磷脂含量和组成。在对照动物中,呼吸3小时期间总磷脂和磷脂酰胆碱的量以及磷脂酰胆碱/鞘磷脂比值增加了2倍以上。拮抗剂使总磷脂和磷脂酰胆碱的增加减少了38 - 62%,而磷脂酰胆碱/鞘磷脂比值的增加减少了61 - 77%。这些数据表明,白三烯和P1受体拮抗剂以及白三烯生物合成抑制剂可抑制新生兔通气诱导的肺表面活性剂分泌增加,并且与组织培养系统的数据一起,支持白三烯和腺苷在表面活性剂分泌的生理调节中的作用。